Adequate research funding is key to furthering developments in lung cancer treatment. Through partnering with foundations, non-profits, corporations and individual donors, the International Lung Cancer Foundation provides funding opportunities each year to facilitate advances and save lives.
Each year, the International Lung Cancer Foundation provides research funding for young and early-career investigators. This funding recognizes scientific excellence and encourages innovation in the fields of lung cancer prevention and translational medicine worldwide.
Our next Research Awards cycle begins on Monday, June 15. Check out our application site for details on the available awards and how to apply.
APPLY for ILCF Awards NOW
Currently, quality data are scarce concerning COVID-19 positive lung cancer patients. COVID-19, or other respiratory coronavirus infections, will likely continue for the foreseeable future and there needs to be a better understanding of how this virus affects lung cancer patients, lung cancer treatment and therapies, and the overall effects on treatment outcomes. The International Lung Cancer Foundation is pleased to join forces with the Lung Ambition Alliance on a new program to fund ground-breaking research related to patients with lung cancer and COVID-19. Collaborative, multidisciplinary applications are encouraged.
APPLY for LAA Grants NOW
Lung Cancer Foundation of America- Bristol-Myers Squibb/IASLC Foundation Young Investigator Research Awards in Translational Immuno-oncology The objective of the LCFA-BMC/IASLCF Young Investigator Research Awards is to support research in translational immune-oncology by early career investigators that aim to improve the care of individuals with lung cancer and to reduce the burden of these diseases. Four awards available/ $200,000 for two years. Free ME from Lung Cancer (FMFLC) and the IASLC Foundation Joint Fellowship Award The FMFLC-IASLC award is designed to fund research that will deliver a meaningful and measurable result for the early detection of lung cancer and that has a high probability of near-term benefit to lung cancer patients or individuals at risk. One award available/ $200,000 for two years.
John’s Legacy Fellowship The objective of the new IASLCF John’s Legacy Fellowship Award is to encourage that the early detection and screening of lung cancer become a standard of care in annual physicals. The fellowship was conceived by IASLCF board member, Lauren Fisher, in memory of her late husband, John Fisher. One award available/ $50,000 for one year. IASLC Foundation Fellowship and Young Investigator Awards Funding for IASLC Foundation Fellowship and Young Investigator Awards provides for the training of research fellows and young investigators who wish to pursue a career in lung cancer diagnosis, treatment, or laboratory research as well as other aspects of the study of lung tumors. Six awards available/ $50,000 for one year. Boehringer Ingelheim IASLC Foundation Chinese Research Fellowship Award Boehringer Ingelheim, in collaboration with the IASLC, have created the Chinese Lung Cancer Fellowship Award to enable a fellow to come to the United States for a one-year research project. The goal of this fellowship is to reward scientific excellence and to encourage innovative and collaborative investigation in the fields of lung cancer prevention, diagnosis and translational research with a potential impact on the management of lung cancer. One award available/ $40,000 for one year. Prevent Cancer Foundation and the IASLC Foundation Joint Research Grant The goal of this Prevent Cancer Foundation/IASLC Foundation joint grant is to reward scientific excellence and to encourage innovative investigations in the field of lung cancer prevention research and translational research with a potential impact on the management of lung cancer. One award available/ $250,000 for one year.